Intact Investment Management Inc. trimmed its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 87.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200 shares of the company's stock after selling 1,390 shares during the quarter. Intact Investment Management Inc.'s holdings in Molina Healthcare were worth $58,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atala Financial Inc acquired a new position in Molina Healthcare in the 4th quarter valued at $74,000. Avantax Advisory Services Inc. lifted its position in shares of Molina Healthcare by 7.6% during the 4th quarter. Avantax Advisory Services Inc. now owns 1,416 shares of the company's stock valued at $412,000 after acquiring an additional 100 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after acquiring an additional 88 shares during the period. Sequoia Financial Advisors LLC lifted its position in shares of Molina Healthcare by 28.2% during the 4th quarter. Sequoia Financial Advisors LLC now owns 1,532 shares of the company's stock valued at $446,000 after acquiring an additional 337 shares during the period. Finally, Daiwa Securities Group Inc. lifted its position in shares of Molina Healthcare by 25.1% during the 4th quarter. Daiwa Securities Group Inc. now owns 26,307 shares of the company's stock valued at $7,657,000 after acquiring an additional 5,282 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Trading Up 0.2 %
Shares of MOH stock traded up $0.73 on Thursday, hitting $315.60. The company had a trading volume of 571,655 shares, compared to its average volume of 607,665. The firm has a market cap of $17.52 billion, a P/E ratio of 15.45, a P/E/G ratio of 1.06 and a beta of 0.56. The stock's 50-day moving average is $298.86 and its two-hundred day moving average is $309.90. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a twelve month low of $262.32 and a twelve month high of $423.92.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.10% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of research firms have recently weighed in on MOH. Stephens reiterated an "equal weight" rating and set a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. StockNews.com downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Monday, March 10th. Truist Financial cut their target price on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. JPMorgan Chase & Co. restated a "neutral" rating and set a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Finally, UBS Group dropped their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $355.69.
View Our Latest Report on MOH
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
